Sanome
The company develops MEMORI, a CE-Class IIb certified AI-powered clinical decision support tool designed to help hospital teams detect patient deterioration earlier. The software integrates directly into existing Electronic Patient Records (EPR) to provide explainable insights into why a patient's health may be declining. It targets clinicians and healthcare trusts to improve frontline productivity, decrease sepsis rates, and reduce hospital length of stay.
Visit websiteLondon, UK
Healthtech
Artificial Intelligence
Clinical Decision Support
Funding summary
- Total raised
- €2.3M
- Funding rounds
- 1
Investors in Sanome
Investors on record for Sanome. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Sanome?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors